Liberty Signs Multi-Year National Strategic Partnership Agreement with the American Diabetes Association
June 07 2007 - 7:00AM
Business Wire
PolyMedica Corporation (NASDAQ: PLMD) today announced that its
wholly owned subsidiary, Liberty Healthcare Group, Inc.
(�Liberty�), the nation's largest mail order diabetes supply
company, has entered into a multi-year National Strategic
Partnership agreement with the American Diabetes Association (ADA).
As a National Strategic Partner, Liberty will support the ADA�s �I
Decide To Fight DiabetesSM" campaign. The �I Decide To Fight
Diabetes� campaign is focused on inspiring people to live healthier
lives and to make better choices when it comes to preventing and
managing diabetes. The campaign is focused on raising funds to
support the mission of the American Diabetes Association � to
prevent and cure diabetes and to improve the lives of all people
affected by diabetes as well as to help people express themselves
as part of a movement to stem the tide against the disease. People
with diabetes, their friends and families, as well as those at
risk, are encouraged to display their commitment by wearing an �I
Decide To Fight Diabetes� charm, t-shirt, or other item available
at the ADA�s web site, www.diabetes.org/IDecide. �By becoming a
National Charter Sponsor of the �I Decide to Fight Diabetes�
campaign, Liberty is helping to amplify the voice of the diabetes
cause,��stated Patrick T. Ryan, Chief Executive Officer of
PolyMedica. �Liberty�s team members are proud to support the
American Diabetes Association in this critical fight against
diabetes.� Liberty will help to further the mission of the ADA and
an important Liberty priority by offering support for the �I Decide
to Fight Diabetes� campaign, which seeks to inspire and empower
patients in leading healthier lives. Liberty patients will benefit
from access to the ADA�s resources. �The ADA needs more champions
in the fight against diabetes, and we appreciate Liberty�s
commitment to people living with diabetes and their support of the
ADA�s mission,��said Larry�C. Deeb, MD, ADA�s President, Medicine
& Science. Today, diabetes is America�s number one health
threat: Nearly 21 million adults and children have diabetes
One-third of them (6.2 million) don't know they have the disease
One in three Americans born in 2000 will develop diabetes in their
lifetime if nothing is done to stem the tide Diabetes kills more
people than breast cancer and AIDS combined For more information on
Liberty, go to www.libertymedical.com. For more information on the
American Diabetes Association and the �I Decide To Fight Diabetes�
campaign, go to www.diabetes.org/IDecide. About PolyMedica
Corporation and Liberty Healthcare Group For more than a decade,
Liberty has been the nation�s largest provider of blood glucose
testing supplies and related services to people with diabetes and
today serves more than 943,000 active diabetes patients. Liberty
also offers a full service pharmacy to meet patients� medication
needs and provides patient education to help its patients better
manage their health conditions. Through proactive patient outreach,
convenient home delivery and administrative support, Liberty makes
it simple for patients to obtain the supplies and medications they
need, while encouraging compliance with physicians� orders. More
information about Liberty and PolyMedica Corporation can be found
at www.libertymedical.com and www.polymedica.com. About ADA The
American Diabetes Association is the nation�s premier voluntary
health organization supporting diabetes research, information and
advocacy. Founded in 1940, the Association has offices in every
region providing services to hundreds of communities. Its mission
is to prevent and cure diabetes and approve the lives of all people
affected by diabetes. For more information, please visit
www.diabetes.org or call 1-800-DIABETES (1-800-342-2382).
Information from both these sources is available in English and
Spanish. This press release contains forward-looking statements as
that term is defined in the Private Securities Litigation Reform
Act of 1995. Such forward-looking statements are subject to risks
and uncertainties, which could cause actual results to differ
materially from those anticipated. Such risks and uncertainties
include, but are not limited to, rules and regulations promulgated
under the Act, unanticipated changes in Medicare reimbursement,
successful participation in new reimbursement programs, outcomes of
government reviews, inquiries, investigations and related
litigation, continued compliance with government regulations,
fluctuations in customer demand, management of rapid growth,
competition from other healthcare product vendors, timing and
acceptance of new product introductions, general economic
conditions, geopolitical events and regulatory changes, as well as
other especially relevant risks detailed in PolyMedica�s filings
with the Securities and Exchange Commission, including its Annual
Report on Form 10-K for the period ended March 31, 2007, and
Quarterly Reports on Form 10-Q for the periods ended June 30, 2006,
September 30, 2006 and December 31, 2006. The information set forth
herein should be read in light of such risks. PolyMedica assumes no
obligation to update the information contained in this press
release.
Polymedica Corp (MM) (NASDAQ:PLMD)
Historical Stock Chart
From Nov 2024 to Dec 2024
Polymedica Corp (MM) (NASDAQ:PLMD)
Historical Stock Chart
From Dec 2023 to Dec 2024